Archives

Vall d’Hebron begins clinical trial of Janssen’s COVID-19 vaccine

July 26, 2021 11:46 am Published by Miguel

Vall d’Hebron suggests that the immune system through a cytotoxic attack of T lymphocytes would cause Parkinson’s disease

July 26, 2021 11:45 am Published by Miguel

The antitumor drug ABTL0812 shows promising results against neuroblastoma

July 26, 2021 11:43 am Published by Miguel

Asthma could protect against COVID-19 in a specific group of asthmatic patients

July 26, 2021 11:42 am Published by Miguel

A study by Vall d’Hebron shows that headache could indicate a better clinical course of COVID-19

July 26, 2021 11:40 am Published by Miguel

A new artificial intelligence tool will help detect whether a liver is useful for transplantation

July 26, 2021 11:38 am Published by Miguel

Vall d’Hebron shows that ECMO can save the life of the most severe COVID-19 patients

July 26, 2021 11:37 am Published by Miguel

15% of severe cases of COVID-19 would have genetic and immunological factors, according to two international studies with the participation of Vall d’Hebron

July 26, 2021 11:36 am Published by Miguel

Vall d’Hebron demonstrate negative effects of lockdown in patients with epilepsy

July 26, 2021 11:34 am Published by Miguel

Vall d’Hebron identifies a key protein to prevent breast cancer metastases

July 26, 2021 11:32 am Published by Miguel